Furthermore, DCs were insensitive to treatment with IκBα phosphorylation inhibitor at the start of infection, with significant differences in pathogen burden only seen at very high concentrations (10 μM) of inhibitor (Fig. S7C). The gene discussed is NFKBIA; the disease is infection.